Atsuhiko Kato

This inventor holds 14 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Jichi Medical University, National Institutes of Biomedical Innovation, Health and Nutrition. Active years: 2002-2026.

USPTO Granted Patents = 14 (Patent Applications = 6)

% Patents Active = 85.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 39(Granted Patents)

Location History:

Gotenba, JP (2002 - 2004)
Shizuoka, JP (2014 - 2024)

Company Filing History:

13 out of 985

Chugai Seiyaku Kabushiki Kaisha

patents

3 out of 33

Jichi Medical University

patents

2 out of 23

National Institutes of Biomedical Innovation, Health and Nutrition

Pharmalogicals Research Pte. Ltd.

patents

6. 1 out of 36

University of Miyazaki

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516115 - COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF IL-8 RELATED DISEASES (2026-01-06),

2. 11965180 - Cancer stem cell population and method for production thereof (2024-04-23),

3. 11858987 - Cancer stem cell-specific molecule (2024-01-02),

4. 11780912 - Composition for prophylaxis or treatment of IL-8 related diseases (2023-10-10),

5. 11767362 - Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies (2023-09-26),

6. 11536713 - Method for searching and screening for target of anti-cancer agent using non-human animal model having NOG established cancer cell line transplanted therein (2022-12-27),

7. 11124773 - Cancer stem cell population and method for production thereof (2021-09-21),

8. 11053308 - Method for treating IL-8-related diseases (2021-07-06),

9. 10934351 - Cancer stem cell-specific molecule (2021-03-02),

10. 10018630 - Cancer stem cell isolation (2018-07-10),

11. 9556264 - Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient (2017-01-31),

12. 8663929 - Method for detection of liver cancer cell using anti-glypican-3 antibody (2014-03-04),

13. 6716628 - Chondrogenesis promoters and indolin-2-one derivatives (2004-04-06),

14. 6500854 - Chondrongenesis promotors and indolin-2-one derivatives (2002-12-31),

Title: Atsuhiko Kato: Pioneering Inventor from Shizuoka

Introduction: Atsuhiko Kato is a renowned inventor hailing from Shizuoka, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Atsuhiko Kato holds several patents in various technological domains, including robotics, artificial intelligence, and renewable energy solutions.

Career Highlights: With a career spanning over two decades, Atsuhiko Kato has worked with leading tech companies and research institutions, spearheading projects that have revolutionized the industry.

Collaborations: Throughout his career, Atsuhiko Kato has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Atsuhiko Kato's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true visionary in the world of inventors.